Mallinckrodt Plans Spin-Off Of Specialty Generics Business
Disposing of its Specialty Generics business and becoming “brands-focused” has long been on Mallinckrodt’s agenda. The firm has now revealed plans to spin-off its generics division, while its remaining company will focus on innovative products.